Lee Financial’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-300
Closed -$27.2K 908
2022
Q4
$27.2K Sell
300
-600
-67% -$50.5K ﹤0.01% 305
2022
Q3
$68K Hold
900
0.01% 227
2022
Q2
$76K Hold
900
0.01% 209
2022
Q1
$79K Hold
900
0.01% 204
2021
Q4
$79K Hold
900
0.01% 211
2021
Q3
$74K Hold
900
0.02% 199
2021
Q2
$82K Hold
900
0.02% 194
2021
Q1
$77K Hold
900
0.02% 197
2020
Q4
$85K Hold
900
0.02% 172
2020
Q3
$78K Hold
900
0.02% 177
2020
Q2
$79K Buy
900
+300
+50% +$25.9K 0.02% 161
2020
Q1
$49K Hold
600
0.02% 174
2019
Q4
$57K Hold
600
0.01% 181
2019
Q3
$52K Hold
600
0.01% 187
2019
Q2
$55K Sell
600
-70
-10% -$5.92K 0.01% 193
2019
Q1
$58K Hold
670
0.01% 186
2018
Q4
$51K Hold
670
0.01% 180
2018
Q3
$52K Sell
670
-110
-14% -$8.13K 0.01% 188
2018
Q2
$52K Hold
780
0.01% 264
2018
Q1
$57K Buy
780
+110
+16% +$8.37K 0.01% 250
2017
Q4
$50K Hold
670
0.01% 188
2017
Q3
$52K Hold
670
0.02% 179
2017
Q2
$50K Hold
670
0.02% 190
2017
Q1
$45K Hold
670
0.02% 179
2016
Q4
$44K Buy
+670
New +$43.5K 0.02% 184

Other funds holding NVS

Lee Financial's NVS Position: Q1 2023 in Review

Lee Financial sold out of Novartis (NVS) in Q1 2023, closing a stake of 300 shares — an estimated $27.2K sold.

Lee Financial first reported a position in NVS in Q4 2016 and held it in 25 quarters. The position peaked at $85K in Q4 2020. 1,180 funds tracked by Wall St. Rank hold NVS as of Q1 2023.

  • Lee Financial reported no remaining Novartis position as of Q1 2023 after selling out during the quarter.
  • Lee Financial sold 300 Novartis shares in Q1 2023, an estimated $27.2K.
  • Lee Financial first reported a position in Novartis in Q4 2016 and held it in 25 quarters.
  • Lee Financial's Novartis position peaked at $85K in Q4 2020.
  • 1,180 funds tracked by Wall St. Rank held Novartis as of Q1 2023.

Based on Lee Financial's 13F filing for Q1 2023, filed 15 May 2023.